THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
批准号:
7369087
负责人:
Michael G. Fried
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The ARF-p53 tumor suppressor pathway is one of the cell?s major defenses against the stimulation of uncontrolled cell division induced by activated cellular and viral oncogene. ARF and/or p53 are mutated in over 70% of human cancers. The inappropriate activation of growth promoting cellular signaling pathways by oncogenes can result in the induction of ARF. The expression of ARF can activate p53 leading to apoptotic cell death or cell cycle arrest. The mechanisms by which the ARF-p53 pathway is regulated remains to be precisely elucidated. The expression of ARF can activate p53 leading to apoptotic cell death or cell cycle arrest. We have shown that the polyoma virus oncogene, PYMT, activates an ARF-induced p53 mediated block. We find that the polyoma virus small T-antigen, PYST, via its ability to bind to cellular protein phosphatase 2A (PP2A), can negate the ARF-induced block to cell division induced by PYMT. We intend to use the PY induction and inhibition of ARF signaling to p53 to better define this important tumor suppressor pathway. Our hypothesis is that the polyoma virus proteins are revealing an important new aspect of the ARF-p53 tumor suppressor signaling circuit, and we plan to use these viral proteins as tools to study its molecular basis. To better define the role of PYMT in activating ARF and as an oncogene, and to define the role of PYST in blocking ARF signaling to p53 we plan to characterize the proteins complexed to PYMT, PYST and members of the ARF-p53 signaling pathway. In the first instance proteins bound to TAP fusion constructs would be identified by Mass Spectrometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:8363758
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2011
-
负责人:Michael G. Fried
-
依托单位:
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:8169752
-
项目类别:
-
资助金额:$0.88万
-
财政年份:2010
-
负责人:Michael G. Fried
-
依托单位:
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:7957391
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2009
-
负责人:Michael G. Fried
-
依托单位:
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:7724198
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2008
-
负责人:Michael G. Fried
-
依托单位:
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:7601844
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Michael G. Fried
-
依托单位:
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY
-
批准号:7181004
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2005
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:7491146
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:7117682
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:6760656
-
项目类别:
-
资助金额:$5.61万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:7282416
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:8106934
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:7034334
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
COOPERATIVE INTERACTIONS IN DNA REPAIR
-
批准号:6879615
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2004
-
负责人:Michael G. Fried
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3522607
-
项目类别:
-
资助金额:$5.2万
-
财政年份:1988
-
负责人:Michael G. Fried
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: